Notice of Rulemaking Without Public Hearing
The Controlled Substance Board will adopt the attached rule creating CSB 2.75 relating to removing FDA approved cannabidiol from schedule V and excluding FDA approved cannabidiol from schedule I, without public hearing under the procedure set forth in s. 961.11(4), Stats.
Submittal of Written Comments
Comments may be submitted to Jon Derenne, Administrative Rules Coordinator, Department of Safety and Professional Services, Division of Policy Development, 4822 Madison Yards Way, P.O. Box 8366, Madison, WI 53708-8366, or by email to DSPSAdminRules@wisconsin.gov. Comments must be received on or before January 14, 2021 to be included in the record of rule-making proceedings.
Initial Regulatory Flexibility Analysis
The proposed rule will not have an effect on small businesses, as defined under s. 227.114 (1).
Agency Small Business Regulatory Coordinator
Controlled Substances Board (CSB)